China MedTech – Continuing the journey towards a globally leading market

China continues to be the most critical market in global MedTech, yet it is more complex with specific competitive dynamics and policy evolution. Doing business as usual will not be sufficient, and the window to change could be tight. MNCs MedTech need to rethink their localization strategy, innovation paths, and commercial differentiation while locals need to continue investing in R&D and explore global market opportunities.